GSK blood cancer drug nearly halves risk of death in late-stage trialIn the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in combination with th...
Gland Pharma launches generic cancer treatment drug in USThe Hyderabad-based company said its product is therapeutically equivalent to Takeda Pharmaceuticals' Velcade for Injection.
Zydus Lifesciences gets USFDA's nod to market generic version of BortezomibThe drug, a generic version of reference listed drug Velcade, will be manufactured at Zydus Hospira, Gujarat.